Kazushige Nirei Hitomi Nakamura Shunichi Matsuoka Yoichiro Yamana Shunichi Yoda Atsushi Hirayama Mitsuhiko Moriyama
10.2169/internalmedicine.56.7948
Intern Med
2017;56(7):787-790.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28381744/
Antiviral Agents / adverse effects Benzimidazoles / adverse effects Fluorenes / adverse effects Hepatitis C / drug therapy Sofosbuvir / adverse effects Tachycardia, Ventricular / chemically induced
Antiviral Agents / adverse effects Benzimidazoles / adverse effects Fluorenes / adverse effects Hepatitis C / drug therapy Sofosbuvir / adverse effects Tachycardia, Ventricular / chemically induced Case Reports Aged Aged, 80 and over Antiviral Agents / therapeutic use Benzimidazoles / therapeutic use Drug Therapy, Combination Female Fluorenes / therapeutic use Humans Risk Factors Sofosbuvir / therapeutic use Antiviral Agents Benzimidazoles Fluorenes ledipasvir Sofosbuvir
PMC5457921
28381744
Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
2017